References
- AmatoBCompagnaRRoccaAFondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patientsDrug Des Devel Ther20161020412046
- RyuJHOlsonEJPellikkaPAClinical recognition of pulmonary embolism: problem of unrecognized and asymptomatic casesMayo Clin Proc19987398738799737225
- PinedaLAHathwarVSGrantBJClinical suspicion of fatal pulmonary embolismChest2001120379179511555511
- Abdel-RazeqHMansourAIsmaelYIncidental pulmonary embolism in cancer patients: clinical characteristics and outcome: a comprehensive cancer center experienceVasc Health Risk Manag2011715315821468175
- BüllerHRDavidsonBLDecoususHMatisse InvestigatorsFondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trialAnn Intern Med20041401186787315172900
- BüllerHRDavidsonBLDecoususHMatisse InvestigatorsSubcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolismN Engl J Med2003349181695170214585937
- RobertsonLKestevenPOral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis [Cochrane Protocol]PROSPERO2015 CRD42015017423. Available from: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015017423Accessed 25 June 2016
- BauerKPros and cons of new oral anticoagulantsHematology Am Soc Hematol Educ Program2013201346447024319220
- KearonCAklEAComerotaAJAmerican College of Chest PhysiciansAntithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest2012141Suppl 2e419Se494S22315268
- LeeAYLevineMNBakerRILow-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancerN Engl J Med2003349214615312853587
- LeeAYKamphuisenPWMeyerGCATCH InvestigatorsTinzaparin vs warfarin for treatment of acute venous thromboembo-lism in patients with active cancer: a randomized clinical trialJAMA2015314767768626284719
- Van der HulleTden ExterPLPlanquetteBRisk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patientsJ Thromb Haemost201614110511326469193
- Available from: http://www.jnj.com/news/all/New-Clinical-Research-Program-Initiated-for-the-Prevention-and-Treatment-of-Life-Threatening-Blood-Clots-in-Patients-with-CancerAccessed June 25, 2016
- Abdel-RazeqHIsmaelYDealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism. A play-it-safe practical approach!Ther Clin Risk Manag2011721321721753883
References
- AmatoBCompagnaRRoccaAFondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patientsDrug Des Devel Ther20161020412046
- SchulmanSShrumJMajeedAManagement of bleeding complications in patients with cancer on DOACsThromb Res2016140Suppl 1S142S14727067968